Arcturus Therapeutics Holdings Inc (ARCT)
16.02
-2.32
(-12.65%)
USD |
NASDAQ |
Nov 15, 16:00
16.25
+0.23
(+1.44%)
After-Hours: 16:52
Arcturus Therapeutics Holdings Free Cash Flow (Quarterly): -23.84M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -23.84M |
| June 30, 2024 | -30.47M |
| March 31, 2024 | -5.797M |
| December 31, 2023 | -1.504M |
| September 30, 2023 | -33.39M |
| June 30, 2023 | 50.45M |
| March 31, 2023 | -36.56M |
| December 31, 2022 | 156.45M |
| September 30, 2022 | -44.59M |
| June 30, 2022 | -36.44M |
| March 31, 2022 | -51.15M |
| December 31, 2021 | -43.62M |
| September 30, 2021 | -18.42M |
| June 30, 2021 | -33.35M |
| March 31, 2021 | -43.07M |
| December 31, 2020 | -7.329M |
| September 30, 2020 | -16.31M |
| June 30, 2020 | -8.963M |
| March 31, 2020 | -12.00M |
| December 31, 2019 | -7.853M |
| September 30, 2019 | -2.995M |
| June 30, 2019 | 9.074M |
| March 31, 2019 | -5.489M |
| December 31, 2018 | -5.988M |
| Date | Value |
|---|---|
| September 30, 2018 | -7.048M |
| June 30, 2018 | -8.479M |
| March 31, 2018 | -0.723M |
| December 31, 2017 | 4.85M |
| September 30, 2017 | -1.814M |
| June 30, 2017 | 1.218M |
| March 31, 2017 | -4.965M |
| December 31, 2016 | 11.70M |
| September 30, 2016 | -6.682M |
| June 30, 2016 | -4.108M |
| March 31, 2016 | -4.46M |
| December 31, 2015 | 22.00M |
| September 30, 2015 | -5.439M |
| June 30, 2015 | -3.915M |
| March 31, 2015 | -4.607M |
| December 31, 2014 | -7.74M |
| September 30, 2014 | -9.499M |
| June 30, 2014 | -5.488M |
| March 31, 2014 | -5.678M |
| December 31, 2013 | -4.848M |
| September 30, 2013 | -2.005M |
| June 30, 2013 | -0.358M |
| March 31, 2013 | -0.181M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-51.15M
Minimum
Mar 2022
156.45M
Maximum
Dec 2022
-12.39M
Average
-21.13M
Median
Free Cash Flow (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 58.90M |
| Bioventus Inc | 10.25M |
| Liquidia Corp | -23.95M |
| Pfizer Inc | 6.063B |
| AIM ImmunoTech Inc | -3.237M |